Our guide on how to get insurance to cover revision bariatric surgery walks through the documentation insurers typically require and how to start that conversation with your provider.
5,7,8 The magnitude of weight loss is a significant factor in the potential benefit of GLP-1RAs in HFpEF patients with obesity
Who Should Avoid Peptide Therapy The following patient profiles are not appropriate candidates for peptide therapy, based on contraindication guidance from Bonza Health and Stem Cell MIA: Current or recent cancer diagnosis: Peptides that elevate IGF-1 or activate angiogenesis pathways present an unacceptable theoretical risk in individuals with active or recently treated malignancy
Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K et al
For example, if the standard dose of Ipamorelin is 200 mcg, and you stack it with CJC-1295 , you might reduce the Ipamorelin dose to 100-150 mcg per injection